Light Rain 44°
Tag:

COVID-19 booster shots

News
COVID-19: Vaccine Targeting Omicron Variant Authorized For Young Children By FDA COVID-19: Vaccine Targeting Omicron Variant Authorized For Young Children By FDA
Covid-19: Vaccine Targeting Omicron Variant Authorized For Young Children By FDA The Food and Drug Administration has authorized the use of updated COVID-19 booster shots targeting the Omicron variant for younger children. The FDA announced the amended emergency use authorization of the bivalent Moderna and Pfizer booster vaccines on Wednesday, Oct. 12. Today, FDA amended the EUA of the Moderna COVID-19 Vaccine, Bivalent and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to authorize their use as a single booster dose in younger age groups. https://t.co/C2Sx5Nkk0R pic.twitter.com/xsPfO2Mek3 — U.S. FDA (@US_FDA) October 12, 2022 The Moderna bivalent booster is autho…

SHARE

by Nicole Valinote
News
COVID-19: Brand-New Research Reveals Which Vaccine Is Most Effective Over Time COVID-19: Brand-New Research Reveals Which Vaccine Is Most Effective Over Time
Covid-19: Brand-New Research Reveals Which Vaccine Is Most Effective Over Time It turns out not all COVID-19 vaccines are created equal. Newly released research published by the US Centers for Disease Control and Prevention (CDC) has found which federally-authorized COVID vaccine is proving to be most effective over time. The studies that have been published found that Moderna’s vaccine is more effective against the virus months after the vaccination series was completed. According to the CDC, the efficacy of the Pfizer vaccine against hospitalization fell from 91 percent to 77 percent after a four-month period following the second shot. Moderna’s efficac…

SHARE

by Zak Failla
News
COVID-19: FDA Likely To Approve Brand-New Time Frame For Booster Shot COVID-19: FDA Likely To Approve Brand-New Time Frame For Booster Shot
Covid-19: FDA Likely To Approve Brand-New Time Frame For Booster Shot The timeline for COVID-19 booster shots may be accelerated as the US Food and Drug Administration (FDA) is expected to approve booster shots for all Americans after six months, not eight, as previously announced. According to reports, as more data is examined by federal health officials, it is more likely that booster shots will be required sooner than later for the Pfizer and Moderna vaccines. Before they can go into arms, the FDA must authorize booster shots for each vaccine. A spokesperson for the agency said that under its general policy it "cannot comment on or confirm the existence" o…

SHARE

by Zak Failla
News
COVID-19: US Expected To Announce Time Frame For All Americans To Get Booster Shots COVID-19: US Expected To Announce Time Frame For All Americans To Get Booster Shots
Covid-19: US Expected To Announce Time Frame For All Americans To Get Booster Shots Federal health officials have outlined their plans for when most Americans should get COVID-19 booster shots after becoming fully vaccinated. Pending authorization from the US Food and Drug Administration (FDA), a plan still being developed would advise Americans to get a COVID-19 booster shot eight months after becoming fully vaccinated to help stave off variants of the virus. Both Pfizer and Moderna, two of the three shots currently being administered in the US, have already submitted initial data to the FDA regarding their booster doses of their COVID-19 vaccines and are awaiting appro…

SHARE

by Zak Failla
News
COVID-19: FDA Expected To Authorize Booster Shots For Immunocompromised People COVID-19: FDA Expected To Authorize Booster Shots For Immunocompromised People
Covid-19: FDA Expected To Authorize Booster Shots For Immunocompromised People The US Food and Drug Administration is expected to move forward quickly with authorization of COVID-19 booster shots for some Americans who are immunocompromised, according to reports. Health officials said that the third shot of the current two-dose Pfizer and Moderna vaccine could be authorized within the next 48 hours, though no official timetable has been set as variants of the virus and COVID-19 mutations continue to cause a surge in new cases. Before a vaccine can be used in new ways outside existing authorization it requires new approval from the FDA. Currently, the Moderna, Pfizer…

SHARE

by Zak Failla